Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.30 CAD
Change Today +0.025 / 9.26%
Volume 21.5K
CZO On Other Exchanges
Symbol
Exchange
Venture
OTC US
As of 3:56 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

ceapro inc (CZO) Snapshot

Open
C$0.27
Previous Close
C$0.27
Day High
C$0.30
Day Low
C$0.27
52 Week High
12/3/14 - C$0.75
52 Week Low
07/15/15 - C$0.18
Market Cap
18.2M
Average Volume 10 Days
17.0K
EPS TTM
C$0.02
Shares Outstanding
61.7M
EX-Date
--
P/E TM
14.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for CEAPRO INC (CZO)

Related News

No related news articles were found.

ceapro inc (CZO) Related Businessweek News

No Related Businessweek News Found

ceapro inc (CZO) Details

Ceapro Inc., a biotechnology company, develops, commercializes, and markets health and wellness products, and technology relating to plant extracts in Canada, the United States, Germany, and other countries. Its products comprise natural active ingredients, including beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; and veterinary therapeutic products, such as an oat shampoo, an ear cleanser, and a dermal complex/conditioner for veterinarians in Japan and Asia. The company’s products and technologies under research and development, or pre-commercial stage include a drug delivery platform using its beta glucan technology to deliver compounds for uses ranging from wound care and therapy to skin care treatments that reduce the signs of aging; an extension to the active ingredients product range; various manufacturing technologies, including Pressurized Gas Expansion drying technology; new oat variety and technologies to increase the content of avenanthramides; and CeaProve, a diabetes test meal to screen pre-diabetes and to confirm diabetes diagnosis. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada.

Founded in 1997

ceapro inc (CZO) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$252.0K
Compensation as of Fiscal Year 2014.

ceapro inc (CZO) Key Developments

Ceapro Inc. Presents at World Congress on Industrial Biotechnology, Jul-19-2015

Ceapro Inc. Presents at World Congress on Industrial Biotechnology, Jul-19-2015 . Venue: Palais des congrès de Montréal, Montréal, Quebec, Canada.

Ceapro Inc. Approves Appointment of Stacy Prefontaine as Corporate Secretary

Ceapro Inc. approved the appointment of Stacy Prefontaine as Corporate Secretary at its annual meeting of shareholders held on June 3, 2015.

Ceapro Inc. Appoints Ulrich Kosciessa to its Board of Directors

Ceapro Inc. announced the appointment of international pharmaceutical industry expert, Ulrich Kosciessa, Ph.D., to the Board of Directors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CZO:CN C$0.30 CAD +0.025

CZO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CZO.
View Industry Companies
 

Industry Analysis

CZO

Industry Average

Valuation CZO Industry Range
Price/Earnings 14.6x
Price/Sales 2.0x
Price/Book 7.6x
Price/Cash Flow 14.4x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEAPRO INC, please visit www.ceapro.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.